Deficient cotinine formation from nicotine is attributed to the whole deletion of the CYP2A6 gene in humans

Publisher Website
Google Scholar
Abstract
Nicotine is mainly metabolized to cotinine by cytochrome P450 (CYP) 2A6. Large interindividual differences in nicotine metabolism have been reported in humans. The purpose of this study was to clarify the relationship between the poor metabolism of nicotine and the existence of the CYP2A6v1 and CYP2A6v2 alleles, and a whole deletion allele of the CYP2A6 gene. The plasma concentrations of nicotine and cotinine were measured in 10 healthy subjects after each smoked one cigarette or chewed one piece of nicotine gum. One subject showed no detectable cotinine level in plasma when smoking and the lowest cotinine level when receiving nicotine gum. The subject was regarded as a poor metabolizer of nicotine by a probit analysis and was found to carry a homozygous whole deletion allele of the CYP2A6 gene. This is the first report to show that deficient cotinine formation in humans is attributed to the whole deletion of the CYP2A6 gene. Clinical Pharmacology & Therapeutics (2000) 67, 57–69; doi: 10.1067/mcp.2000.103957

This publication has 0 references indexed in Scilit: